Genelux Corporation is a biotechnology company focused on developing innovative gene therapies for cancer treatment
The company specializes in harnessing the power of engineered oncolytic viruses, which are designed to selectively target and destroy cancer cells while stimulating the immune system to recognize and attack tumors. Through its proprietary platform, Genelux aims to provide advanced therapeutic options for patients with various types of cancer, working towards improving outcomes and quality of life.
Genelux shares are trading lower by 40.7% during Friday's session. The company announced the pricing of an underwritten offering of 6.875 million shares.
Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth-quarter financial results. Quanex Building Products shares fell 10.7% to $30.95 on Friday.
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales. ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates of $258.41 million.
